#MSCOVID19. Trial results of interferon Beta

#

You can read….best wishes

Efficacy and safety of interferon beta-1a in treatment of severe COVID-19: A randomized clinical trialDavoudi-Monfared, E., Rahmani, H., Khalili, H., Hajiabdolbaghi, M., Salehi, M., Abbasian, L., Kazemzadeh, H., Yekaninejad, M. S.10.1101/2020.05.28.20116467 — Posted: 2020-05-30

Objectives: To the best of our knowledge, there is no published study regarding use of IFN beta-1a in the treatment of severe COVID-19. In this randomized clinical trial efficacy and safety of IFN β-1a has been evaluated in patients with severe COVID-19. Methods: Forty-two patients in the interferon group received IFN beta-1a in addition to the standard of care. Each 44 micrograms/ml (12 million IU/ml) of interferon beta-1a was subcutaneously injected three times weekly for two consecutive weeks. The control group received only the standard of care. Primary outcome of study was time to reach clinical response. Secondary outcomes duration of hospital stay, length of ICU stay, 28-day mortality, effect of early or late administration of IFN on mortality, adverse effects and complications during the hospitalization. Results: As primary outcome, time to the clinical response was not significantly different between the IFN and the control groups (9.7 +/- 5.8 vs. 8.3 +/- 4.9 days respectively, P=0.95). On day 14, 66.7% vs. 43.6% of patients in the IFN group and the control group were discharged, respectively (OR= 2.5; 95% CI: 1.05- 6.37). The 28-day overall mortality was significantly lower in the IFN then the control group (19% vs. 43.6% respectively, p= 0.015). Early administration significantly reduced mortality (OR=13.5; 95% CI: 1.5-118). Conclusion: Although did not change time to reach the clinical response, adding to the standard of care significantly increased discharge rate on day 14 and decreased 28-day mortality. Clinical Trial Registration ID #IRCT20100228003449N28.

About the author

MouseDoctor

1 comment

  • I would have been surprised if this hadn’t have worked. People are dying from severe covid due to the body’s immune response and so anything that dampens this down is going to be positive. Ie anything that prevents the cytokine storm. Beta interferon seems q good as such prevention. Getting to this stage of the disease is the worry as it appears about 1 in 3 die and this drug seems to improve those odds. (Thumbs up emoji)

By MouseDoctor

Translate

Categories

Recent Posts

Recent Comments

Archives